Total Payments
$17,340
2024 Payments
$3,095
Companies
74
Transactions
637
Medicare Patients
11,845
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$16,419 (94.7%)
Other$697.90 (4.0%)
Education$223.22 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,419 | 622 | 94.7% |
| Long term medical supply or device loan | $697.90 | 7 | 4.0% |
| Education | $223.22 | 8 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,891 | 80 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,768 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,154 | 21 | $0 (2022) |
| Lilly USA, LLC | $1,023 | 24 | $0 (2024) |
| GENZYME CORPORATION | $981.11 | 21 | $0 (2023) |
| Celgene Corporation | $648.64 | 28 | $0 (2024) |
| PFIZER INC. | $647.24 | 36 | $0 (2024) |
| Merck Sharp & Dohme LLC | $638.39 | 30 | $0 (2024) |
| Gilead Sciences, Inc. | $613.97 | 25 | $0 (2024) |
| Daiichi Sankyo Inc. | $586.24 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,095 | 99 | Novartis Pharmaceuticals Corporation ($918.51) |
| 2023 | $3,286 | 110 | E.R. Squibb & Sons, L.L.C. ($463.76) |
| 2022 | $3,120 | 117 | Lilly USA, LLC ($319.32) |
| 2021 | $1,814 | 49 | AstraZeneca Pharmaceuticals LP ($435.88) |
| 2020 | $964.55 | 44 | AstraZeneca Pharmaceuticals LP ($296.50) |
| 2019 | $2,117 | 74 | TESARO, Inc. ($379.80) |
| 2018 | $1,801 | 78 | Novartis Pharmaceuticals Corporation ($220.99) |
| 2017 | $1,142 | 66 | PFIZER INC. ($224.78) |
All Payment Transactions
637 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Oncology | ||||||
| 12/10/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Oncology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.52 | General |
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Oncology | ||||||
| 11/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/31/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $13.82 | General |
| 10/29/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $29.26 | General |
| Category: Hematology | ||||||
| 10/24/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $0.80 | General |
| Category: Hematology | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.46 | General |
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.03 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $20.01 | General |
| 10/15/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.75 | General |
| 10/02/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,864 | 39,300 | $783,532 | $198,894 |
| 2022 | 46 | 2,773 | 45,971 | $1.1M | $307,098 |
| 2021 | 62 | 3,592 | 51,534 | $1.1M | $310,628 |
| 2020 | 65 | 3,616 | 59,068 | $1.3M | $372,291 |
Total Patients
11,845
Total Services
195,873
Medicare Billing
$1.2M
Procedure Codes
208
All Medicare Procedures & Services
208 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 360 | $122,040 | $34,570 | 28.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 24 | 24 | $88,944 | $26,346 | 29.6% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 21 | 4,150 | $95,450 | $24,069 | 25.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 42 | 188 | $71,064 | $18,103 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 253 | $60,467 | $16,167 | 26.7% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 26 | 26 | $17,680 | $10,416 | 58.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 362 | 1,092 | $9,828 | $9,173 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 363 | 1,130 | $32,770 | $8,599 | 26.2% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 22 | 20,400 | $81,600 | $8,196 | 10.0% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 11 | 4,680 | $23,400 | $6,473 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 39 | $18,486 | $5,312 | 28.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 24 | 26 | $14,300 | $4,107 | 28.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 45 | 84 | $15,876 | $3,886 | 24.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 54 | 288 | $17,568 | $3,233 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $10,419 | $3,004 | 28.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 261 | $18,009 | $2,703 | 15.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 23 | 114 | $9,006 | $2,446 | 27.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 60 | 138 | $8,142 | $2,349 | 28.8% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 30 | 35 | $12,040 | $2,118 | 17.6% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 13 | 23 | $6,371 | $1,538 | 24.1% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 18 | 60 | $5,040 | $1,315 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,470 | $1,232 | 27.6% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 18 | 34 | $5,304 | $835.78 | 15.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 16 | 710 | $19,880 | $602.44 | 3.0% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 11 | 13 | $4,550 | $553.04 | 12.2% |
About Rafael Blanco, M. D
Rafael Blanco, M. D is a Hematology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164474615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rafael Blanco, M. D has received a total of $17,340 in payments from pharmaceutical and medical device companies, with $3,095 received in 2024. These payments were reported across 637 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($16,419).
As a Medicare-enrolled provider, Blanco has provided services to 11,845 Medicare beneficiaries, totaling 195,873 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 208 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Tampa, FL
- Active Since 05/16/2006
- Last Updated 08/02/2022
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1164474615
Products in Payments
- OPDIVO (Biological) $1,381
- KISQALI (Drug) $899.73
- ZEJULA (Drug) $673.79
- LYNPARZA (Drug) $641.83
- REBLOZYL (Biological) $579.62
- KEYTRUDA (Biological) $502.91
- Enhertu (Drug) $465.11
- VERZENIO (Drug) $397.81
- CALQUENCE (Drug) $378.28
- LIBTAYO (Biological) $362.48
- DARZALEX (Biological) $315.03
- TECENTRIQ (Biological) $301.98
- IMBRUVICA (Drug) $276.27
- CABOMETYX (Drug) $254.68
- Trodelvy (Drug) $250.13
- IBRANCE (Drug) $249.91
- RETEVMO (Drug) $247.04
- ADCETRIS (Biological) $225.63
- Lenvima (Drug) $225.61
- SIR-Spheres Microspheres (Device) $177.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Tampa
Rami Komrokji, M.d, M.D
Hematology — Payments: $850,782
Hematology $850,782
Dr. Julia Cogburn, M.d, M.D
Hematology — Payments: $133,076
Hematology $133,076
Dr. Robert Weaver, Md, MD
Hematology — Payments: $110,649
Hematology $110,649
Alan List, Md, MD
Hematology — Payments: $94,305
Hematology $94,305
Dr. David Wright, Md, MD
Hematology — Payments: $82,377
Hematology $82,377
Lubomir Sokol, Md, MD
Hematology — Payments: $27,903
Hematology $27,903